Heikki Joensuu

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Julia Johansen

Professor

Copenhagen University Hospital

DENMARK

View details

Jodi Carter

Associate Professor

University of Alberta

CANADA

View details

Harri Sihto

University of Helsinki

FINLAND

View details

Harri Kalevi Mustonen

University of Helsinki

FINLAND

View details

Mikael Eriksson

Associate professor, Senior Consultant

Skåne University Hospital

SWEDEN

View details

Pirkko-Liisa Kellokumpu-Lehtinen

Professor of Radiotherapy and Oncology, emerita

Tampere University

FINLAND

View details

Pia Osterlund

Karolinska University Hospital

SWEDEN

View details

Liisa Porra

University of Helsinki

FINLAND

View details

Peter Hohenberger

Professor of Surgical Oncology and Thoracic Surgery

University of Heidelberg Bioquant

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Heikki Joensuu

Research Interests

Explore related searches

Contact this professor

Articles (10)

Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.

Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer

KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial

KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib

From Nuclear Reactor-Based to Proton Accelerator-Based Therapy

Ocular Administration of Palonosetron in the Prevention of Cisplatin-Induced Nausea and Vomiting

An effective drug combination for the first-line treatment of advanced gastrointestinal stromal tumor

First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis

Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for Head and Neck Cancer Treated with BNCT

Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients

Collaborators (9)

Julia Johansen

Jodi Carter

Harri Sihto

Harri Kalevi Mustonen

Mikael Eriksson

Pirkko-Liisa Kellokumpu-Lehtinen

Pia Osterlund

Liisa Porra

Peter Hohenberger

Make your next move.